FDA Concept Paper: Drug Products That Present Demonstrable Difficulties for...
...For these reasons, the drug formulation of a TDS product, including the interaction of all TDS.....In addition, careful control of the impurities and degradation products in the drug substance and drug formulation.....The composition of an MDI formulation and the physicochemical content of each of the formulation..
http://www.fda.gov/cder/fdama/difconc.htm (score=100)

MDI and DPI Drug Products
...establish a set of criteria to which a drug substance or drug product should conform using.....an internal reservoir containing sufficient formulation for multiple doses that are.....recommended for inclusion in the application regarding the components, manufacturing..
http://www.fda.gov/cder/guidance/2180dft.pdf (score=33)

/a//content.14388
...Mixing, granulating, milling, molding, of components, drug product containers, formulating.....Therefore, under the Federal Food, all established standards, specifications, Drug, and.....characteristics, formulation, equipment, to human or animal health or if there are.. (b..
http://www.fda.gov/cder/dmpq/fr5396.pdf (score=492)

HUMAN DRUG CGMP NOTES March 1997
...Welcome to another edition of Human Drug CGMP Notes, our periodic memo on CGMP for human.....84(c)(6), Testing and approval or rejection of components, drug product containers, and.....formulation is 100% of the product label claim; therefore each 100 gms of the API used "as..
http://www.fda.gov/cder/hdn/cnotes37.htm (score=162)

Sterile Drug Products Produced by Aseptic Processing
...Any manual or mechanical manipulation of the sterilized drug, components, containers, or.....Drug product components, containers, closures, storage time limitations, and manufacturing equipment.....formulation processing stage.  The total time for product filtration should be limited to..
http://www.fda.gov/cder/guidance/5882fnl.htm (score=162)

Guidance for Industry
...Direct inoculation into the drug formulation provides an assessment of the effect of drug.....products shall be excluded from direct contact with components, drug product containers.....prevent the contamination of equipment, components, drug product containers, closures..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1874dft.pdf (score=115)

Guidance for Industry
...Direct inoculation into the drug formulation provides an assessment of the effect of drug.....products shall be excluded from direct contact with components, drug product containers.....prevent the contamination of equipment, components, drug product containers, closures..
http://www.fda.gov/cder/guidance/1874dft.pdf (score=115)

...84 pertains to the testing and approval or rejection of components, drug product containers, and.....formulation, equipment, or processes, including reprocessing, that could affect product.....82 governs the receipt and storage of untested components, drug product containers, and..
http://www.fda.gov/cber/genadmin/cgmp.txt (score=113)

Document
...Mixing, granulating, milling, molding, of components, drug product containers, formulating.....Therefore, under the Federal Food, all established standards, specifications, Drug, and.....characteristics, formulation, equipment, to human or animal health or if there are.. (b..
http://www.fda.gov/cber/genadmin/cgmp.pdf (score=113)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug.....accelerator operation, radiochemical synthesis, purification steps, and formulation of the.....evaluation can include testing of the material (see Section VI, Control of Components, 276..
http://www.fda.gov/cder/guidance/4259dft.pdf (score=69)

GUIDE TO INSPECTIONS OF DOSAGE FORM DRUG MANUFACTURER'S - CGMPR'S
...Determine the validity, and accuracy of the firm's inventory system for drug components.....Air supplied to the non-sterile preparation or formulation area for manufacturing.....Components must be handled in accordance with the drug CGMP's including components used in the research and..
http://www.fda.gov/ora/inspect_ref/igs/dose.html (score=69)

PET Drug Products … Current Good Manufacturing Practice (CGMP)
...or lot, of a PET drug typically consists of one multiple-dose vial containing the PET drug.....accelerator operation, radiochemical synthesis, purification steps, and formulation of the.....evaluation can include testing of the material (see Section VI, Control of Components, 276..
http://www.fda.gov/cder/guidance/4259dft.PDF (score=67)

...A change in the primary packaging components for any drug product when the primary packaging components.....COMPONENTS AND COMPOSITION Changes in the qualitative or quantitative formulation.....Different reporting categories are recommended once CDER has reviewed certain components/materials in association with a drug product..
http://www.fda.gov/cder/guidance/3516fnl.doc (score=66)

Guidance For the Submission of Documentation for Sterilization Process
...other processes should be addressed as each applies to the drug product,sterile packaging.....The sterilization and depyrogenation processes used for containers,closures, equipment.....flow (movement) of product and components from formulation to finished..dosage form should be identified..
http://www.fda.gov/cber/gdlns/sterval.pdf (score=66)

Changes to an Approved NDA or ANDA
...This is applicable to any material where such procedures are necessary, including drug substance, drug.....A change in an analytical procedure used for testing components, packaging components, the final intermediate.....Changes in the qualitative or quantitative formulation, including inactive ingredients, as..
http://www.fda.gov/cder/guidance/2766fnl.htm (score=66)

þÿ
...recommended once CDER has reviewed certain components/materials in association with a drug.....Changes in the qualitative or quantitative formulation, including inactive ingredients, as.....quality of drug substances, drug products, intermediates, raw materials, reagents, components, in-process..
http://www.fda.gov/OHRMS/DOCKETS/98fr/1999d-0529-gdl0003.pdf (score=66)

þÿ
...recommended once CDER has reviewed certain components/materials in association with a drug.....Changes in the qualitative or quantitative formulation, including inactive ingredients, as.....quality of drug substances, drug products, intermediates, raw materials, reagents, components, in-process..
http://www.fda.gov/cder/guidance/3516fnl.pdf (score=66)

For the Submission of Documentation for Sterilization Process
...other processes should be addressed as each applies to the drug product,sterile packaging.....The sterilization and depyrogenation processes used for containers,closures, equipment.....flow (movement) of product and components from formulation to finished..dosage form should be identified..
http://www.fda.gov/cder/guidance/cmc2.pdf (score=66)

Premarin
...In most cases, it will be clear what components of a drug make clinically meaningful contributions to the.....This unexpected characteristic of the Premarin formulation meant that generic copies were.....Under the Federal Food, Drug, and Cosmetic Act, for a generic drug product with Premarin as the reference listed drug to be..
http://www.fda.gov/cder/news/celetterjw.htm (score=23)

Las Vegas Injury Lawyer